Literature DB >> 21777670

Distinct functional roles of Akt isoforms for proliferation, survival, migration and EGF-mediated signalling in lung cancer derived disseminated tumor cells.

Nicole Grabinski1, Kai Bartkowiak, Katharina Grupp, Burkhard Brandt, Klaus Pantel, Manfred Jücker.   

Abstract

Single disseminated tumor cells (DTC) can be detected in the bone marrow (BM) from 20% to 60% of patients with various tumors including non-small cell lung cancer (NSCLC). Detection of DTC in the BM of NSCLC patients is associated with poor prognosis and may be responsible for metastatic relapse. However, the functional properties of DTC are widely unknown. Here, we performed the first functional analysis of DTC focusing on the activation of the PI3K/Akt signalling pathway and the functional roles of Akt isoforms. In vitro kinase assays revealed a high activity of Akt3 in NSCLC-derived DTC. Proliferation and survival of DTC was reduced by depletion of Akt3 and to a lesser extend by Akt1, but not after depletion of Akt2. The major effect of Akt3 on the proliferation of DTC was associated with an Akt3-mediated regulation of both, cyclin D1 and cyclin D3, whereas Akt1 regulated the expression of cyclin D1 only. In contrast all three Akt isoforms, especially Akt2, were involved in the regulation of migration. Analysis of signalling events downstream of distinct Akt isoforms revealed that expression levels of urokinase-type plasminogen activator and its receptor were decreased after knockdown of Akt1 and Akt3. In addition, EGF-stimulated proliferative and anti-apoptotic signals are mediated by Akt1 and Akt3 in DTC. Finally, by immunofluorescence staining of primary DTC from BM samples of lung cancer patients, pAkt(S473) and Akt3 positive DTC were detected in vivo. Our data demonstrate that Akt1 and notably Akt3 regulate proliferation, survival, migration and EGF-mediated signal transduction in NSCLC-derived DTC.
Copyright © 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21777670     DOI: 10.1016/j.cellsig.2011.07.003

Source DB:  PubMed          Journal:  Cell Signal        ISSN: 0898-6568            Impact factor:   4.315


  44 in total

Review 1.  Tumor metastasis: moving new biological insights into the clinic.

Authors:  Liling Wan; Klaus Pantel; Yibin Kang
Journal:  Nat Med       Date:  2013-11       Impact factor: 53.440

Review 2.  Novel approaches to target the microenvironment of bone metastasis.

Authors:  Lorenz C Hofbauer; Aline Bozec; Martina Rauner; Franz Jakob; Sven Perner; Klaus Pantel
Journal:  Nat Rev Clin Oncol       Date:  2021-04-19       Impact factor: 66.675

3.  Role of Akt2 in regulation of metastasis suppressor 1 expression and colorectal cancer metastasis.

Authors:  E Agarwal; C M Robb; L M Smith; M G Brattain; J Wang; J D Black; S Chowdhury
Journal:  Oncogene       Date:  2017-01-09       Impact factor: 9.867

4.  Dual Inhibition of PI3K-AKT-mTOR- and RAF-MEK-ERK-signaling is synergistic in cholangiocarcinoma and reverses acquired resistance to MEK-inhibitors.

Authors:  Florian Ewald; Dominik Nörz; Astrid Grottke; Bianca T Hofmann; Björn Nashan; Manfred Jücker
Journal:  Invest New Drugs       Date:  2014-08-26       Impact factor: 3.850

5.  Integrated analysis reveals that STAT3 is central to the crosstalk between HER/ErbB receptor signaling pathways in human mammary epithelial cells.

Authors:  Chunhong Gong; Yi Zhang; Harish Shankaran; Haluk Resat
Journal:  Mol Biosyst       Date:  2014-10-15

6.  High expression of heme oxygenase-1 is associated with tumor invasiveness and poor clinical outcome in non-small cell lung cancer patients.

Authors:  Jong-Rung Tsai; Hui-Min Wang; Po-Len Liu; Yung-Hsiang Chen; Ming-Chan Yang; Shah-Hwa Chou; Yu-Jen Cheng; Wei-Hsian Yin; Jhi-Jhu Hwang; Inn-Wen Chong
Journal:  Cell Oncol (Dordr)       Date:  2012-10-10       Impact factor: 6.730

Review 7.  Epithelial-mesenchymal plasticity in circulating tumor cells.

Authors:  Catherine Alix-Panabières; Sonja Mader; Klaus Pantel
Journal:  J Mol Med (Berl)       Date:  2016-12-24       Impact factor: 4.599

8.  Hypoxia-inducible factor-1α mediates the toll-like receptor 4 signaling pathway leading to anti-tumor effects in human hepatocellular carcinoma cells under hypoxic conditions.

Authors:  Xiaoyu Zhang; Shuchen Li; Mingrong Li; Haiying Huang; Jingyuan Li; Changwei Zhou
Journal:  Oncol Lett       Date:  2016-06-13       Impact factor: 2.967

9.  Akt3 knockdown induces mitochondrial dysfunction in human cancer cells.

Authors:  Minjee Kim; Young Yeon Kim; Hye Jin Jee; Sun Sik Bae; Na Young Jeong; Jee-Hyun Um; Jeanho Yun
Journal:  Acta Biochim Biophys Sin (Shanghai)       Date:  2016-03-13       Impact factor: 3.848

Review 10.  Tumor cell dissemination: emerging biological insights from animal models and cancer patients.

Authors:  Yibin Kang; Klaus Pantel
Journal:  Cancer Cell       Date:  2013-05-13       Impact factor: 31.743

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.